1. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. MMWR Morbid Mortal Wkly Rep 1998, 47(RR-20):1–58.
2. Updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors. MMWR Morbid Mortal Wkly Rep 2000, 49:185–189.
3. Perlman DC, El-Helou P, Salomon N: Tuberculosis in patients with human immunodeficiency virus infection. Semin Respir Infect 1999, 14:344–352.These articles summarize recent clinical developments in and recommendations for the management of HIV-related tuberculosis.
4. Artenstein AW, Kim JH, Willimas WJ, et al.: Isolated peripheral tuberculous lymphadenitis in adults: current clinical and diagnostic issues. Clin Infect Dis 1995, 20:876–882.
5. Kourbeti IS, Maslow MJ: Nontuberculous mycobacterial infections of the lung. Curr Infect Dis Rep 2000, 2:193–200.This paper provides an excellent summary of the epidemiology, microbiology, and treatment of NTM infections.